LinkedIn facebook twitter youtube
News archive
Recent news

Led by International Myeloma Society (IMS), the 17th International Myeloma Workshop (IMW) will be held in Boston, USA, from 12 to 15 September.  During the Workshop the latest breakthroughs in myeloma and related diseases will be presented and analysed by leading doctors, researchers and patient advocates in the community.  Find here the full agenda.

Myeloma Patients Europe (MPE) will be attending this important myeloma scientific congress and will regularly post updates from the key scientific and clinical sessions on our communications channels.

Additionally, the MMPredict team, a pan-European Horizon 2020 project MPE is a member of, will present a poster entitled “Validation of SKY92 high and low risk prognostication”.

Following the IMW, MPE will publish a summary of the key findings for the myeloma and AL amyloidosis communities.

Keep an eye out on our website and social media channels for further information.

Recent news

» Myeloma diagnosis can take over 5 months and require more than 4 medical consultations with more than 3 different specialists

» The European Medicines Agency (EMA) approves Melflufen (Pepaxti®) for the treatment of refractory myeloma

Leave a Reply

Your email address will not be published.

I accept the Privacy Policy